clinical trial · NCT05080946
Using Aspirin to Improve Immunological Features of Ovarian Tumors
H. Lee Moffitt Cancer Center and Research Institute·early phase1·recruiting·n = 100
Ovarian CancerFallopian Tube CancerPeritoneal CancerAspirin 325mgPlacebo
brief summary
The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
started
Nov 2, 2021
primary completion
Jul 1, 2026
completion
Dec 1, 2026
last updated
Apr 1, 2026
official title
Pilot Study to Assess the Efficacy of Aspirin to Improve Immunological Features of Ovarian Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol